Sign inJoin waitlistJoin the waitlist

CN

Charles Nakar

Physician · Innovative Hematology

Credentials: · ·

History

Innovative Hematology
2022–Present

Pediatric Hematology/Oncology
New York Presbyterian Hospital
2003–2006
Cornell University Medical CollegeMemorial Sloan-Kettering Cancer CenterWeill Medical College at Cornell University
2002–2003
Gurion University of the Negev
1999–2002
Rabin Medical Center
1998–1999
Ben-Gurion University of the Negev Faculty of Health Sciences
1994–1998

Research

Rapamycin-sensitive pathway regulates mitochondrial membrane potential, autophagy, and survival in irradiated MCF-7 cells
Cancer Research · 2005 · 193 citations
Plasminogen replacement therapy for the treatment of children and adults with congenital plasminogen deficiency
Blood · 2018 · 42 citations
Prompt immune tolerance induction at inhibitor diagnosis regardless of titre may increase overall success in haemophilia A complicated by inhibitors: experience of two U.S. centres
Haemophilia · 2015 · First of 8 authors · 41 citations

AS
Amy Shapiro
17 papers
Heather McDaniel
4 papers
AR
Angeli Rampersad
2 papers
Brandon Hardesty
2 papers
Jeremy Lorber
2 papers
Joachim Yahalom
2 papers
MK
Manjusha Kumar
2 papers
RD
Robert Decker
2 papers
SG
Sweta Gupta
2 papers
Aliyah Khan-Serrano
1 paper
Amol Sura
1 paper
Andrew Thomson
1 paper · 1 as a resident

Clinical trials

Hemlibra in Mild Hemophilia A
Sub-investigator · Recruiting · Phase 4
Indiana Hemophilia &Thrombosis Center, Inc.
2022–2027
Study of Individuals Affected With Hypoplasminogenemia
Sub-investigator · Recruiting
Indiana Hemophilia &Thrombosis Center, Inc.
2018–2029